Gene Query: SLC8B1

Dataset Description Geneva Score
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 32.39
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 28.83
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 28.8
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 28.49
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 26.44
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 26.31
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 24.67
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 22.89
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 21.78
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 20.36
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 18.37
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 17.42
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 17.42
ZIKV infection of monocytes activates inflammasome pathways 15.87
Effect of Hotair overexpression in human breast cancer cell lines 15.01
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 14.93
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 14.29
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 14.03
RNA-seq of naive and primed ES cells 13.88
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 13.59
Identification of global regulators of T-helper cell lineage specification 13.59
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 13.41
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 13.25
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 13.25
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 13.1
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 13.1
naive T cell heterogeneity after neonatal thymectomy 12.93
Global Gene Expression Changes in Cholangiocytes Treated with TGF-beta 12.77
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 12.68
Effect of from Human Umbilical Vein Endothelial Cells 12.62
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 12.45
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 12.45
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 11.89
RNA-seq of resting and activated CD4+ T cells +-JQ1 11.38
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 11.2
Transcriptome of activated human and mouse MAIT cells 11.12
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 11.01
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 11.01
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 11.01
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 10.84
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 10.72
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 10.72
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 10.45
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 10.45
Tumor exosome integrins determine organotropic metastasis 10.21
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 10.07
AMPK signaling for naïve pluripotency 10.0
AMPK signaling for naïve pluripotency [Hs] 10.0
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 9.72
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 9.62
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 9.62
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 9.6
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 9.41
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 9.29
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  9.27
Pharmacologic inhibition of STAT5 in AML 9.12
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 9.11
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 9.11
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 9.01
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 8.99
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 8.99
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 8.91
Inhibition of TNBC metastasis by Gpx1 8.9
Accurate annotation of human protein-coding small open reading frames 8.89
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 8.89
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 8.85
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 8.85
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 8.83
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 8.68
Gene expression changes associated with resistance to tagraxofusp (SL-401) 8.65
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 8.59
Genome wide expression change by RNF168 knocking down in NEC cells 8.31
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 8.2
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 8.18
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 8.18
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.06
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 8.05
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.03
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 7.96
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 7.96
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 7.88
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 7.88
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 7.84
RNAseq of IL-36 stimulated primary human keratinocytes 7.84
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 7.82
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 7.63
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.59
The effect of PPARG inhibition on human angiomyolipoma cells 7.49
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.43
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 7.43
RNA Seq of HMVEC under hypoxia 7.43
Statins modulate endothelial transcriptional profile by inhibiting EZH2 7.31
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 7.28
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.07
Effect of nuclear IL-33 on gene expression 7.02
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 7.0
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 6.88
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 6.88
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 6.81
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.79
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.73
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 6.66
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 6.6
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 6.45
Stem cell and neurogenic gene-expression profiles link prostate basal cells to aggressive prostate cancer 6.29
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 6.26
Transcriptional profiling of CD45RO+CD57+CD4+ T cells 6.04
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 6.03
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 5.96
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 5.94
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 5.93
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 5.93
CD95/Fas ligand mRNA is toxic to cells 5.92
Expression profiling of converted and control dermal BJ fibroblasts 5.88
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 5.88
RNA-seq of cells with TET1 knockout 5.85
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 5.84
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.8
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 5.79
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 5.76
UBC9 knockdown in bladder cancer T24 cell lines 5.69
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 5.67
GATA3-mediated chromatin reprogramming in breast cancer cells 5.65
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 5.63
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 5.6
Generation of Patient-Matched Malignant and Normal Primary Cell Cultures from Clear Cell Renal Cell Carcinoma Patients 5.59
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 5.58
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 5.56
RNA expression analysis upon JMJD1C depletion 5.56
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 5.45
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 5.44
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 5.44
Efficient derivation of microglia-like cells from human pluripotent stem cells 5.43
The Human Testis Cell Atlas via Single-cell RNA-seq 5.33
Molecular Criteria for Defining the Naive Human Pluripotent State 5.24
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 5.22
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 5.22
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.21
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.21
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.21
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 5.2
LNCaP treated with iBET 5.18
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.16
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 5.15
Electronic cigarettes 5.1
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 5.1
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 5.08
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 4.91
Fbxo32 mediated gene expression program underlies EMT and metastasis 4.87
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 4.78
Potential signaling pathways and gene signatures associated with brain metastases in NSCLC patients 4.77
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 4.74
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 4.74
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 4.7
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 4.69
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 4.67
RNA-seq of stable and unstable section of human atherosclerotic plaques 4.65
Gene expression analysis of immortalized human liver progenitor-like cells in culture 4.6
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.58
TAF1 is critical for AE driven leukemogenesis 4.58
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 4.57
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 4.57
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.56
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 4.48
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 4.46
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 4.46
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 4.46
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 4.44
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.43
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.41
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.41
Exploring ILF2 regulatory genes by next-generation sequencing 4.41
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 4.37
RNA-seq of MCF10A cells and CAF 4.33
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 4.31
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 4.31
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 4.31
MeRIP-seq for heat shock in B-cell lymphoma cells 4.26
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.23
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 4.16
Trascriptome of thyroid cancer-induced macrophages 4.16
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 4.11
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 4.09
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 4.07
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 4.03
CircRNAome diversity in human mature B-cells, T-cells and monocytes 4.0
MOF acetyl transferase regulates transcription and respiration in mitochondria 4.0
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 4.0
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 3.99
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 3.98
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 3.98
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 3.91
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 3.91
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 3.9
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 3.9
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 3.9
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.87
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.87
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.87
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 3.85
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 3.84
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.84
Transcriptome wide analysis of classically and alternatively activated macrophages 3.82
The pause-initiation limit restricts transcription activation in human cells 3.81
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.81
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 3.8
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 3.8
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 3.78
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 3.78
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 3.77
NAPRT activation of macrophages 3.75
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 3.74
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 3.74
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 3.73
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 3.73
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 3.72
Proliferation-correlated expression 3.71
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.71
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.71
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 3.68
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 3.62
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.57
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 3.57
Effect of drugs on transcriptomic profiles 3.57
Transcriptomic and gene ontology profiling of the human corneal cell types 3.57
Microglia innatly develop within cerebral organoids 3.55
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 3.51
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.49
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 3.49
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 3.49
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 3.47
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 3.46
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 3.46
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.46
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 3.43
A role for ZNF598 in post-transcriptional gene regulation 3.4
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.38
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 3.38
Transcription control by the ENL YEATS domain in acute leukemia 3.38
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 3.35
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 3.35
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 3.35
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 3.35
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 3.34
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 3.32
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 3.3
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 3.3
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.29
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.29
Transcriptome of Stabilin-1 siRNA transfected human monocytes 3.29
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 3.27
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 3.27
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 3.26
Regulating Interleukin-2 activity with engineered receptor signaling clamps 3.26
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 3.23
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 3.23
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.21
Lysine benzoylation is a novel histone mark 3.19
Lysine benzoylation is a novel histone mark [RNA-seq] 3.19
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.19
Transcriptome analysis of peripheral blood monocytes 3.18
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 3.18
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 3.17
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 3.16
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 3.15
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 3.15
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.14
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 3.14
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 3.12
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 3.11
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 3.1
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 3.09
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 3.09
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 3.09
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 3.08
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.08
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 3.08
Clinker: visualizing fusion genes detected in RNA-seq data 3.08
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.07
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 3.06
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 3.06
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.06
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 3.03
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 3.03
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 3.0
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.99
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 2.97
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 2.95
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.88
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 2.86
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.86
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 2.83
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 2.83
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.81
Transcriptome analysis of SKI knock-out in HL60 cells 2.77
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.77
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.77
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.73
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 2.65
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.64
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.58
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 2.57
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.57
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 2.56
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 2.56
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 2.56
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.56
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 2.55
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 2.55
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 2.54
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 2.54
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 2.52
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 2.5
Targeted enhancer activation by a subunit of the integrator complex 2.44
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.43
Gene expression profile difference among renal location in a stone former 2.42
Silencing SPIB in attached and floating state of H1703 lung cancer cells 2.41
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 2.4
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.36
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.35
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.34
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 2.33
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 2.29
Primary Human B-cell Temporal Response to CD40L Stimulation 2.19
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 2.18
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.17
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 2.17
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.12
RNAseq of T-ALL upon long non coding rna purturbation 2.11
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 2.05
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.05
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 2.03
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 2.03
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 2.03
Dermal endothelial cells of type 2 diabetic patients 2.03
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.02
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.02
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 2.01
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 2.01
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 1.99
Random mono-allelic expression in MECP2-mutated cells 1.98
MRTF activates TEAD-YAP target gene expression 1.97
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.96
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.96
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 1.94
RNA sequencing of T-ALL (COG study) 1.93
Analyses of T-ALL (COG study) 1.93
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 1.92
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.91
Sequence dependency and regulatory function of dimeric NOTCH1/RBPJ complexes on coding and non-coding transcription in T-lymphoblastic leukemia 1.88
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.86
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.84
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 1.83
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 1.83
Functional significance of the HIV-1 Tat signature amino acid residues 1.81
Generation and functional characterization of MDSC-like cells 1.81
Downregulation of LATS kinases alters p53 to promote cell migration 1.8
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 1.79
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 1.78
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 1.77
Fusion discovery in breast cancer cell line 1.74
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 1.72
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.69
oxLDL exposed trained monocytes 1.67
Transcriptomes of oxLDL exposed trained monocytes 1.67
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.61
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 1.59
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.59
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 1.58
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.58
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.57
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.57
Investigate A2M treatment on human prostate cancer xenograft in mice 1.54
Investigate A2M treatment on human prostate cancer and mouse liver 1.54
RNA sequencing (RNA-SEQ) of EPAS1 knockdown by siRNA in endothelial cells 1.52
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 1.5
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 1.48
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 1.48
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 1.48
The transcriptome and chromatin accessbility landscape of mammalian germline 1.46
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 1.46
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.44
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 1.43
Transcriptomic analysis of ERR alpha orphan nuclear receptor 1.41
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 1.39
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 1.39
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.39
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing. 1.36
Gene expression profiling in follicular lymphoma (FL) samples and paired transformed follicular lymphoma (tFL) (n=6 samples) 1.36
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 1.34
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.32
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 1.3
Transcriptome Profiling of Human Primary Monocytes 1.26
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.22
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.21
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.17
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.17
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.17
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.15
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 1.14
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.13
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 1.13
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.09
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 1.09
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.08
Gene expression profile in breast cancer cells 1.07
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.07
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.04
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 1.04
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.04
Transcriptomes of human monocytes after ex vivo exposure to uric acid 1.04
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 1.01
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.01
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.0
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 1.0
Transcriptomes in healthy and CHB fetal hearts 0.99
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 0.98
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 0.97
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.97
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.97
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.97
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 0.95
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 0.94
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.93
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 0.92
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 0.86
Human ovarian granulosa cell transcriptome 0.86
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.83
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 0.82
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.82
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.79
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.79
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.78
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.78
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 0.77
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.75
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 0.72
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.71
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.7
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.69
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.67
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.66
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 0.64
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.62
Oncogenic roles of ARID5B in T-ALL 0.62
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.62
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.6
miRNAs affected by antagomiR-17 treatment 0.6
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 0.6
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.55
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 0.55
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.53
Identification of long noncoding RNAs in T-ALL cell lines 0.51
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.49
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 0.49
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.46
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.46
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 0.45
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.43
MAIT cell RNA sequencing 0.42
Human Airway Smooth Muscle Transcriptome Changes in Response to Asthma Medications 0.41
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.4
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.4
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.39
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 0.39
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.38
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 0.37
Ribosome profiling upon inhibition of eIF4A 0.37
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.37
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 0.37
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.36
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.36
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.32
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 0.32
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.31
Bone marrow derived human B cells [normal proB] 0.31
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 0.27
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.26
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.26
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.26
Gene Expression Analysis of HUVEC Seeded rBEL Contructs at Low and High Phases of Glucose Consumption 0.25
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 0.25
RNA sequencing of Asthmatic Human Airway Smooth Muscle Cells II 0.25
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.25
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.21
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.2
Gene expression analysis of breast cancer cell-lines 0.2
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 0.17
Gene expression profile of CRC-derived HILEC 0.13
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.12
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.12
Deep RNA sequencing of the human placental transcriptome 0.1
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.07
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.07
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.07
mRNA recovered upon RNF219 IP. [RNA-IP] 0.06
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 0.05
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation